The TERT-promoter mutations upregulate telomerase activity, allowing cancer cells to survive, and prior studies have shown TERT-mutant melanomas to have earlier recurrence and progression, as well as resistance to treatment.29,30. This evidence concerns the gene TERT and melanoma.